---
figid: PMC4184571__prp20001-e00006-f6
figlink: /pmc/articles/PMC4184571/figure/fig06/
number: F6
caption: Putative mechanism for protective effects of cilostazol against retinal damage
  induced by ischemia/reperfusion. The schematic demonstrates the putative mechanism
  of cilostazol interference in ischemia/reperfusion (I/R)-induced disruptions of
  retinal function including the production of tumor necrosis factor-α (TNF-α) and
  the activation of nuclear factor-κB (NF-κB) and activator protein 1 (AP-1). These
  effects of cilostazol lead to protective effects on retinal cell death and endothelial
  damage, resulting in decreasing expression levels of ZO-1 and claudin-5.
pmcid: PMC4184571
papertitle: Cilostazol prevents retinal ischemic damage partly via inhibition of tumor
  necrosis factor-α-induced nuclear factor-kappa B/activator protein-1 signaling pathway.
reftext: Fumiya Ishizuka, et al. Pharmacol Res Perspect. 2013 Oct;1(1):e00006.
pmc_ranked_result_index: '187208'
pathway_score: 0.9377397
filename: prp20001-e00006-f6.jpg
figtitle: Putative mechanism for protective effects of cilostazol against retinal
  damage induced by ischemia/reperfusion
year: '2013'
organisms:
- Homo sapiens
ndex: 138ca1e9-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4184571__prp20001-e00006-f6.html
  '@type': Dataset
  description: Putative mechanism for protective effects of cilostazol against retinal
    damage induced by ischemia/reperfusion. The schematic demonstrates the putative
    mechanism of cilostazol interference in ischemia/reperfusion (I/R)-induced disruptions
    of retinal function including the production of tumor necrosis factor-α (TNF-α)
    and the activation of nuclear factor-κB (NF-κB) and activator protein 1 (AP-1).
    These effects of cilostazol lead to protective effects on retinal cell death and
    endothelial damage, resulting in decreasing expression levels of ZO-1 and claudin-5.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOSL1
  - JUND
  - JUN
  - FOS
  - FOSL2
  - NFKB1
  - TNF
  - TJP1
  - FOSB
  - JUNB
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: ZO-1
  symbol: ZO-1
  source: hgnc_alias_symbol
  hgnc_symbol: TJP1
  entrez: '7082'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
chemicals: []
diseases: []
figid_alias: PMC4184571__F6
redirect_from: /figures/PMC4184571__F6
figtype: Figure
---
